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In the general population, the risk of developing sunlight­
induced skin cancer increases as age increases. During 
the aging process, many biologic factors contribute to the 
increased risk of developing cancer, including increasing 
cumulative carcinogenic exposure and increased cellular 
susceptibility to DNA damage induced by carcinogens. 
The latter is probably due to an age-related decrease in 
cellular DNA repair capacity (DRC). Secondary to this 
decrease in DNA damage repair associated with aging, 
oncogene activation and amplification also increase, as 
does the frequency of defects in tumor suppressor genes. 
All these factors lead to carcinogenesis. Population studies 
T hat DNA repair has a role in the etiology of sunlight­induced skin cancer is implicated by the rare genetic disease xeroderma pigmentosum (XP). Deficient DNA repair and an extraordinarily high incidence of sunlight­induced skin cancers are coup led in XP patients, who 
develop skin cancer more than 40 y earlier than the general population 
(Cleaver and Kraemer, 1989). This phenomenon led researchers to 
pursue DNA repair as a biomarker for cancer susceptibility in the 
general population. It is evident that the risk of developing sunlight­
induced skin cancer in the general population increases as age increases 
(Scotto et ai, 1983). Age-related cancer risk can be either genetically 
determined, as seen in XP patients, or environmentally related, because 
excessive damage induced by sunlight may not be repaired efficiendy 
by DNA repair systems impaired by increasing age. During aging, 
many biologic factors contribute to the increased risk of developing 
cancer, including cumulative carcinogenic exposure and increasing 
cellular susceptibility to damage induced by carcinogens (Cohen, 1994). 
The latter is probably due to decreased cellular DNA repair capacity 
(DRC). Secondary to this decrease in DNA damage repair associated 
with aging, oncogene activation and amplification also increase, as 
does the frequency of defects in tumor suppressor genes. All these 
factors lead to carcinogenesis. 
Most common cancers are considered to be the result of an 
interaction between genetic and environmental factors (Strong, 1977; 
Knudson, 1991). It is well recognized that host susceptibility has a 
significant effect on all stages of carcinogenesis (Committee on Biologic 
Markers of the National Research Council, 1987). Biomarkers for 
genetic susceptibility to cancer are essential for identifying individuals 
at high risk of developing cancer, and therefore are the key for 
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using peripheral blood lymphocytes, transformed 
lymphoblastoid cells, and primary skin fibroblasts have 
shown that human DRC decreases with increasing age. 
The decrease in DRC is also correlated with an increased 
mutation rate. Reduced DRC may thus be one of the 
underlying biologic mechanisms for the age-related 
increase in risk of skin cancer. Therefore, it is important 
to take the effect of age on DNA repair into account in 
population studies of DNA repair and skin cancer risk. 
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successful and cost-effective cancer prevention . Cancer susceptibility 
factors include metabolic isozymes of enzymes such as cytochrome 
P450 (Ayesh et ai, 1984) and DNA repair enzymes (Setlow, 1985) that 
influence the rate of DNA damage removal and the formation of 
mutations and so can increase the host's cancer risk. The crucial role 
of DNA repair in the etiology of cancer was fIrst elucidated in patients 
with the autosomal recessive genetic disease XP, which involves a 
defect in the repair of ultraviolet radiation (UV)-induced DNA damage 
(Cleaver, 1968). Patients with XP have a 2000-fold increased risk of 
sunlight-induced skin cancer and also an increased frequency in the 
cancers of internal organs (Cleaver and Kraemer, 1989). The UV 
component of sunlight induces the formation of covalent bonds 
between adjacent pyrimidines in DNA, generating photoproducts such 
as cyclob utane dipyrimidine dimers and pyrimidine-pyrimidone (6--4) 
lesions (Sedow, 1966), which are mutagenic if not repaired and may 
lead to carcinogenesis (Setlow, 1978). XP cells cannot efficiently 
repair these photoproducts or similar damage induced by chemical 
carcinogens. These discoveries led to the theory that a highly proficient 
DNA repair process is essential for preventing tumor formation; 
however, the ability to repair such DNA damage varies in humans, 
even among XP patients (Cleaver and Kraemer, 1989). XP represents 
the lower range of DRC in humans, but individuals in the general 
population who do not have XP but have a somewhat reduced DRC 
may also be at an increased risk of developing cancer. 
ROLE OF DNA REPAIR IN PHOTO CARCINOGENESIS 
Most skin cancers are undoubtedly induced by sunlight, as evidenced 
by the association between sunlight exposure and the incidence of skin 
cancers in epidemiologic studies (Silverstone and Searle, 1970; Glass 
and Hoover, 1989; Gallagher et ai, 1990; Kricker et ai, 1994). The 
incidence of and mortality from both melanoma and nonmelanoma 
skin cancers are still increasing (Glass and Hoover, 1989; Weinstock, 
1993). The role of DNA repair in sunlight-induced skin cancer is 
evident in XP patients, who have a more than lOOO-fold increased 
risk of developing both melanomas and nonmelanoma skin cancers, 
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Table I. Potential biologic markers for aging and age-related diseases 
Marker Assay Measurement 
Gene mutations 
DNA strand break 
Genomic instability 
Chromosomal aberration 
DNA methylation 
Single strand confonnation polymorphism, DNA sequencing, flow cytometry 
Comet assay. elution assay, polymerase chain reaction 
Frequeucy of mutation 
DNA damage and removal 
Mutator phenotype 
Chromosome damage and repair 
Gene expression and regulation 
DNA repair capacity 
Microsatellite and loss of heterozygosity analyses 
Cytogenetic analyses 
Genomic and gene specific methylation 
DNA repair 
Apoptosis 
Survival. unscheduled DNA synthesis, host-cell reactivation, comet and adduct assay 
Morphologic and DNA fragmentation assays, flow cytometty Cell cycle regulation 
Telomerase Measurement of telomerase activity 
particularly early in life (Kraemer et ai, 1994). Sunlight also induces 
characteristic molecular changes in oncogenes and tumor suppressor 
genes (Suarez et aI, 1989; Sato et ai, 1993). For example, the p53 
tumor suppressor gene is frequently mutated in most human cancers, 
and its spectrum of mutations often provides a clue to cancer etiology 
(Harris, 1996). In skin cancer, the major photoproduct pyrimidine 
dimers, at most frequently mutated sites in p53 in skin cancer, are 
repaired slowly (Tomaletti and Pfeifer. 1994), and preferential repair 
ofUV-induced damage in the transcribed strand of p53 is essential for 
nonnal p53 function (Ford et ai, 1994). Loss of p53 function further 
impairs nucleotide excision repair (Li et ai, 1996), the major DNA 
repair pathway for removing photoproducts (Friedberg, 1985). UV­
induced photoproducts, if left unrepaired , undergo mutation fIxation, 
which results in the so-called UV-fIngerprint mutations (C�T or 
CC�TT transitions) found in ras and p53 in skin carcinomas on sun­
exposed body sites in XP patients (Suarez et aI, 1989; Sato et ai, 1993) 
and in the general population (Ananthaswamy et ai, 1988; Brash et aI, 
1991; Ziegler et ai, 1993 ; Kanjilal et ai, 1993; Nakazawa et aI, 
1994). In addition, unrepaired DNA damage can initiate systemic 
immunosuppression that contributes to cutaneous tumorigenicity 
(Kripke et ai, 1992). Subsequent loss of chromosome 9q and inactivation 
of a single p53 allele is often found in the tumor tissues of more 
advanced cases (Riet et ai, 1994). Clearly, DNA repair plays a central 
role in the initiation of photocarcinogenesis (Black et aI, 1997) . 
RECENT EVIDENCE FOR AGE-RELATED DECLINE IN 
DNA REPAIR 
There are many laboratory methods for investigating the biologic 
effects of aging and many different ways of measuring DNA repair 
(Table I). Nucleotide excision repair is one of the most important 
repair pathways for removing the bulky DNA lesions induced by UV 
light and some chemical carcinogens (Friedberg, 1985). This repair 
entails damage recognition, incision, excision, elongation, and ligation 
(Sancer. 1994). There are laboratory assays for measuring damage 
removal, damage or repair-dependent fonnation of single-strand breaks 
(the comet assay; Tice and Strauss, 1995), and uptake of substrate for 
unscheduled DNA synthesis in response to DNA damage (Evans and 
Nonnan, 1968). These assays technically measure intennediate steps 
of nucleotide excision repair (Friedberg, 1985). Because these assays 
were designed for laboratory investigations, they are comprehensive 
but often expensive and time consuming, so that it is difficult if not 
impossible to apply them to large samples, and the interpretation of 
some of the assays, such as the unscheduled DNA syntheSis assay, is 
subjective and must therefore be perfonned by well-trained laboratory 
scientists. More importantly, cells being investigated for unscheduled 
DNA synthesis, one of the most frequently measured parameters in 
previous population studies. are often damaged in the process. In 
contrast, the. host-cell reactivation assay measures the expression prod­
ucts of a reactivated gene that has been damaged in vitro. transfected 
into undamaged host cells (e.g., lymphocytes), and successfully repaired 
(Athas et al. 1 991) . The repair process measured includes all steps of 
nucleotide excision repair. The assay overcomes the problems that arise 
from using damaged cells whose normal repair mechanism may be 
compromised, and it is a relatively fast, inexpensive, and objective way 
of measuring overall DRC. It has been shown that the assay is 
repeatable. reliable, and feasible for relatively large population studies 
(Wei et al. 1993, 1996a, b; Cheng et al. 1996). 
Cellular senescence 
Although there have been few studies of age-related changes in 
DNA repair in humans, and although the hypothesis that there is an 
age effect on DNA repair is still debated (Shaddock et aI, 1993), there 
is some recent evidence for an age-related decline in DRC that is 
biologically plausible and consistent with the observed increase in age­
related mutation rate measured by different methods and in various 
human cell types (Table II). In a hospital-based case-control study of 
88 patients with newly diagnosed basal cell carcinoma (BCC) and of 
135 healthy controls ranging in age from 20 to 60 y old, Wei et al 
investigated age-related DRC in peripheral blood lymphocytes with 
the host-cell reactivation assay (Wei et ai, 1993). Based on the estimates 
from a linear regression model, DRC decreased 0.61% per year 
(p < 0.05) in the healthy subjects. In keeping with tlle XP paradigm, 
cases who developed their fIrst BCC at young ages had lower DRC 
than the controls . Cases who developed their fIrst cancers at later ages 
had DRC similar to those of controls. This suggests that poor DNA 
repair is associated with precocious skin aging as manifested by early 
age at fIrst BCC. After controlling for the subjects' ages, the age at 
first onset of BCC was positively correlated with DRC (p < 0.05), 
indicating that the lower their DNA repair, the earlier the age of onset 
of BCC. This is evidence that cancer susceptibility related to DNA 
repair is characterized by an early age of onset of cancer in the general 
population as well as in XP patients . 
Randerath et al (1993) examined the adduct levels in brain DNA 
from 20 humans ranging from newborns to 100 y olds and in rats by 
the nuclease P1-enhanced version of the 32P-postlabeling assay. 
Although the nature of the adducts measured was not well defIned, 
adduct levels increased in h= brain with increasing age, as had 
also been shown in the arumal experiments. Human brain DNA is 
thought to undergo progressive covalent modifIcations during aging. 
The age-related increase in the adduct levels may have resulted from 
an age-related decline in DNA repair of such adducts. In another, 
independent investigation, Barnett and King (1995) demonstrated that 
single-strand DNA breaks in untreated lymphocytes were significantly 
more cornmon in individuals 65-69 y old than in those 35-39 y old, 
which is consistent with the notion that there is an age-related decline 
in DNA repair. There may also be genetically determined heterogeneity 
in DNA repair in nonnal individuals of the same age (Hanawalt, 199 1) . 
DNA repair heterogeneity associated with aging has also been observed 
in specifIc regions of DNA (Bohr et aI, 1986; Bohr and Anson, 1995). 
AGE-RELATED MUTATION RATE AS FURTHER EVIDENCE 
FOR AGE-RELATED DECLINE IN DNA REPAIR 
Mutations characteristic of UV light exposure are found in skin 
tumors (Ananthaswamy et ai, 1988; Brash et ai, 199 1) , which suggests 
involvement of abnonnal DNA repair. Because half of patients with 
skin cancers in the general population are less than 55 y old (Cleaver 
and Kraemer, 1989), an age-related decline in DNA repair may be 
responsible for the mutations observed in the tumors of young patients. 
Moriwaki et al (1996) demonstrated an age-related decrease in DRC 
and an increase in mutation frequency. Using the host-cell reactivation 
assay with a transient expression vector (Athas et ai, 1991), Moriwaki 
et al (1996) measured DNA repair capacity in cultured skin fibroblasts 
from 20 nonnal subjects aged 3-96 y. They also measured the mutation 
frequency of a stable expression vector irradiated with UV light in 
lymphoblastoid cell lines from 15 nonnal donors ranging in age from 
4 to 96 y. Surprisingly, they found a 0.6% per year decrease in DRC 
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Table n. Recent evidence for involvement of aging in DNA repair in humansa 
Age No. of Cell type Change with 
Marker Method (y) subjects used aging References 
DNA repair 
DRC HCR 20-60 135 T cell Decrease Wei et al (1993) 
DNA adducts 32p-postlabeling 0-100 20 Brain cell Increase Randerath et al (1993) 
SSD ELISA/MCA-DlB 35--69 55 MNC Increase Barnett and King (1995) 
Mutation 
Glycophorin FC/MCA-PE 0-96 397 RBC Increase Akiyama et al (1995) 
HPRT CFAl6TG 0-96 131 T cell Increase Akiyama et al (1995) 
CFA/6TG 19-64 140 T cell Increase Jones et al (1995) 
T cell receptor FC/PCA-CD3 0-96 358 T cell Increase Akiyama et al (1995) 
'HeR, host-cell reactivation; SSD, single strand DNA; ELISA, enzyme-linked immunosorbent assay; MCA, monoclonal antibody; FC, flow cytometry; PE, phycoerythrin; HPRT, 
hypoxanthlne phosphoribosyltransferase; CFA, colony-formation assay; 6TG, 6-thioguanine; PCA, polyclonal antibody; MNC, mononucleate cell; RBC, red blood cell. 
of the cultured skin fibroblasts, which is identical to our previously 
reported age-related decline in DNA repair in peripheral lymphocytes 
from healthy subjects 20-60 y old (Wei et ai, 1993). More interestingly, 
Moriwaki et al also found the same increase of 0.6% per year in the 
plasmid mutation frequency. These findings revealed a strong inverse 
correlation between the loss of DRC and an increase in mutation 
frequency and are consistent with the findings of other studies (Cole 
et ai, 1988, 1992; Tates et ai, 1989; King et ai, 1994) that demonstrated 
an age-related increase in the spontaneous mutation rate of the 
hypoxanthine phosphoribosyltransferase locus. It is therefore biologic­
ally plausible that an increase in persistent DNA damage resulting from 
impaired DRC is associated with the aging process. 
REDUCED DNA REPAIR AND RISK OF CANCER 
About 80% of all reported skin cancer cases are BCC (Scotto et ai, 
1974, 1983). Because most BCC are clinically less aggressive than 
squamous cell carcinomas, the patients with BCC often do not undergo 
radiotherapy and chemotherapy, which may affect the results of studies 
using peripheral blood lymphocytes. Also, the high cure rate for BCC 
minimizes survival bias in epidemiologic studies. A relationship between 
sunlight exposure and BCC has been demonstrated in many epidemio­
logic studies (Silverstone and Searle, 1970; Glass and Hoover, 1989; 
Kricker et ai, 1994) .  In our population-based study described above, 
we tested the usefulness ofDRC as a biomarker of cancer susceptibility 
and investigated the association between host DRC and risk ofBCC. 
Reduced DRC was associated not only with a family history of skin 
cancer and an early onset of skin cancer but also with a more than 
4-fold increased risk ofBCC among those with high sunlight exposure, 
after adjustment for age (Wei et ai, 1993). A decrease in DRC was 
significandy correlated with an increase in the number of skin tumors 
(Wei et ai, 1994). These data are also consistent with the observation 
that in the general population , patients with prior history of skin 
cancers had an increased risk of developing new primary nonmelanoma 
skin cancers (Kangas et ai, 1992; Frankel et ai, 1992) . 
A similar decrease in DRC was also observed in melanoma patients 
compared with healthy controls. In a pilot study of 51 melanoma cases 
and 49 controls, we found that cases were three times more likely than 
controls to have reduced DRC, indicating that reduced DRC played 
a role in sunlight-induced melanoma (Wei et ai, 1996a). Wei et al 
obtained a similar fmding in a case-control study of lung cancer in 
which a well-studied tobacco-related carcinogen, benzo[a]pyrene diol 
epoxide, was used instead of UV light to damage the reporter gene 
(Wei et aI, 1996b). Reduced DNA repair was more common in young 
cases «65 y; p < 0.05) and in smokers (p < 0.05) and was also 
correlated with a decreased rate of removal of benzo[a]pyrene diol 
epoxide-DNA adducts in lymphocytes (Li et ai, 1996; Wei and Spitz, 
1997). These fmdings suggest that individuals with reduced DRC are 
also at increased risk for smoking-related lung cancer. Furthermore, 
the results of unscheduled DNA synthesis studies on the relationship 
of individual DRC and risk of developing cancer, support the hypothesis 
that decreased overall DRC in mononuclear leukocytes is associated 
with increased risk of colon cancer (pero et aI, 1983) and, in women, 
breast cancer (Kavacs et ai, 1986). 
In some studies there was no significant association between DRC 
capacity and risk of skin cancers. In a case-control study of 86 patients 
with nonme1anoma skin cancer (61 with BCC and 25 with SCC) and 
87 healthy controls matched on age (44-68 y) residing in Australia, 
Hall et al (1994) found no evidence of reduced DRC in either BCC 
or SCC patients. This discrepancy may be due to differences in the 
age range, sample sizes, extent of sunlight exposure, and genetic 
background of the cases and controls. It is conceivable that the 
quantitative difference in DRC between patients and controls is much 
smaller for sporadic skin cancers than for XP, which would necessitate 
a larger sample to detect the difference. In addition, reduced DRC is 
most likely to be found in young patients with skin cancer, and the 
overexposure to sunlight that could occur in areas like Australia could 
have overwhelmed the effect of age on DRC. 
CONCLUSIONS AND FUTURE DIRECTION 
In summary, age is a well-documented risk factor for cancer. Recendy, 
substantial evidence has accumulated for an age-related decline in 
DNA repair associated with an age-related increase in the frequency 
of somatic mutation and increased risk of developing skin cancer. 
Defects in DNA repair genes may lead to early onset of cancer in the 
general population as well as in XP patients. Published reports indicate 
that the susceptible groups, as measured by reduced DRC, are young 
patients with skin cancers and patients with multiple skin cancers. 
Theoretically, susceptible individuals require less sunlight exposure to 
develop skin cancer, as do XP patients . This information should be 
considered in future population studies on aging and DNA repair in 
skin carcinogenesis. Further evaluation of DNA strand breaks as 
measured by the comet assay (Tice and Strauss, 1995), of oxidative 
damage to DNA such as by 8-oxo-7,8-dihydro-2'-depxyquanosine 
(Loft and Poulsen, 1996) and of modification of DNA such as by 
DNA adducts (Philips, 1997) ,  will facilitate assessment of the effect of 
age on DNA repair capacity and the subsequent risk of developing 
cancer. More studies are warranted to better characterize how age 
affects DNA repair in relation to carcinogenesis. Assays that are simple, 
economical, and use lymphocytes for measuring and monitoring DNA 
damage and repair in population studies, will play an important role 
in achieving this goal. 
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